Sage Journals: Discover world-class research

Retricted access

Research article

First published 2003-10

Duration of Anticoagulant Therapy after Initial Idiopathic Venous Thromboembolism

Lawrence A Frazee, Diane L Chomo

Annals of Pharmacotherapy

Retricted access

Research article

First published 2025-10

Impact of Apixaban Lead-In Therapy Duration After Parenteral Anticoagulation on Bleeding in Patients Treated for Venous Thromboembolism

Lauren Jackson, Amanda Gillion, Jacob Marler

Journal of Pharmacy Practice

Retricted access

Review article

First published 2013-3

Postintervention duration of anticoagulation in venous surgery

A J Ten Cate-Hoek, M H Prins, C H A Wittens [...]

Phlebology: The Journal of Venous Disease

Free access

Research article

First published 2016

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?

Alex C. Spyropoulos, Ron Preblick, Winghan J. Kwong [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2010-09

What is the optimum duration of anticoagulation for the management of patients with idiopathic deep venous thrombosis and pulmonary embolism?

TM Hyers, HG Shetty, IA Campbell

Journal of the Royal College of Physicians of Edinburgh

Open access

Research article

First published 2021

Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International,Observational WHITE Study

Gualtiero Palareti, Angelo A. Bignamini, Michela Cini [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2020

Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register

Emilia Antonucci, Ludovica Migliaccio, Maria Abbattista [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 1929-2

Duration of Anticoagulant Action of Heparin in Vivo in Relation to Dosage.

Paul Gross

Experimental Biology and Medicine

Retricted access

Research article

First published 2011-3

OPTIMAL DURATION OF ANTICOAGULATION IN IDIOPATHIC VENOUS THROMBOEMBOLISM SHOULD BE DETERMINED BY ULTIPLE VARIABLES

Journal of the Royal College of Physicians of Edinburgh

Retricted access

Correction

First published 2021-4

Withdrawn: Filter Clotting,Anticoagulation and Duration of Sled in Patients with Covid-19 and Acute Kidney Injury

Journal of Investigative Medicine

Search results